Evidence map›Paper›PMID 30563624›Full record

ArticleAtencion primaria2018

[Making balances between the risks and benefits of pharmacological treatment in dementia, chronic pain and anticoagulation in elderly persons].

María José Fernández Domínguez, Mercedes A Hernández Gómez, Araceli Garrido Barral, María Jesús González Moneo

Open access · goldAbstract read
In one paragraph

Article in Atencion primaria, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Benefits of Dog-Assisted Therapy in Patients with Dementia Residing in Aged Care Centers in Spain.International journal of environmental research and public health · 2021
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

María José Fernández DomínguezGrupo de Trabajo de Atención al Mayor de la semFYC y AGAMFEC. Electronic address: chefernandez7@gmail.com.
Mercedes A Hernández GómezGrupo de Trabajo de Atención al Mayor de la semFYC y AGAMFEC.
Araceli Garrido BarralGrupo de Trabajo de Neurología, Sección Demencias de la semFYC.
María Jesús González MoneoGrupo de Trabajo de Neurología, Sección Demencias de la semFYC.
Spanish Society of Family and Community Medicine · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In dementia, specific drugs and psychotropic drugs used for psychotic and behavioral symptoms have limited efficacy. Adverse effects may be important given the age and comorbidity of the patients. It is necessary, frequently, its withdrawal, planned together with the family, monitoring the response and offering non-pharmacological treatment alternatives. Chronic pain is suffered by 25-76% of the elderly who live in a community and is more frequent in women. The treatment is multidisciplinary, establishing realistic objectives, individualizing it, starting with lower doses of drugs and continuously reevaluating to control side effects and to get the correct level of analgesia. The prevalence of atrial fibrillation increases with age and is underdiagnosed. ACO is recommended with dicoumarin or direct oral anticoagulants not antagonists of vitamin K, in patients with AF older than 65 years unless contraindicated, to reduce embolic risk, confirming subgroup analyzes similar efficacy in prevention of stroke.

Indexed as

AgedAnalgesicsAnticoagulantsAntidepressive AgentsAtrial FibrillationCholinesterase InhibitorsChronic PainContraindications, DrugDementiaDeprescriptionsEmbolismFemaleHumansMaleMedical OveruseNootropic AgentsAnalgesicsAnticoagulantsAntidepressive AgentsCholinesterase InhibitorsNootropic AgentsAncianoAtrial fibrillationChronic painDemenciaDementiaDolor crónicoElderlyFibrilación auricularTherapeuticsTratamientos

Identifiers

PMID30563624
PMCPMC6836956
OpenAlexW2905069809

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.